Aura Biosciences, Inc.

As of May 21, 2025, the market trend is mildly bearish, supported by daily moving averages and monthly indicators, despite some mixed signals from weekly metrics.

Aura Biosciences, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $27 million and a market cap of $383.19 million. The company has no dividend yield and negative return on equity.

As of Jun 18, Aura Biosciences, Inc. has a market capitalization of 383.19 million and reported net sales of 0.00 million with a net profit of -94.69 million over the last four quarters. Shareholder's funds are 151.97 million, and total assets amount to 182.50 million.